Precigen (PGEN) Inventory (2014 - 2026)

Precigen's (PGEN) quarterly Inventory came in at $14.7 million in Q1 2026, up 53.69% on a QoQ basis from $9.6 million in Q4 2025.

Precigen (PGEN) Inventory (2014 - 2026) Analysis & Trends

Precigen (PGEN) has 11 years of Inventory data on file, last reported at $14.7 million in Q1 2026.

On a quarterly basis, Inventory changed N/A year-over-year to $14.7 million in Q1 2026; TTM through Mar 2026 was $14.7 million, a N/A change from a year earlier, with the FY2025 full-year figure at $9.6 million, changed N/A from the prior year.
Inventory for Q1 2026 stood at $14.7 million, up from $9.6 million in the prior quarter.
Over the last five years, Inventory for PGEN reached as high as $14.7 million in Q1 2026 and fell as low as $219000.0 in Q3 2022.
Historically, Inventory has averaged $5.8 million across 3 years, with a median of $3.1 million in 2025.
On a YoY basis, Inventory climbed as much as 19.68% in 2022 and fell as far as 98.04% in 2022.
Year by year, Inventory stood at $287000.0 in 2022, then surged by 3238.33% to $9.6 million in 2025, then jumped by 53.69% to $14.7 million in 2026.
Per Business Quant data, the three most recent Inventory figures were $14.7 million in Q1 2026, $9.6 million in Q4 2025, and $3.1 million in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Inventory (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	681.59 Mn
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	1.77 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	3.10 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	371.00 Mn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Precigen	1.96 Bn	1.96 Bn	20.69 Mn	14.73 Mn

Download Data